SPP1 and non-small cell lung carcinoma: To examine the influence of SPP1 expression on the outlook of NSCLC, survival analysis curves were utilized to assess the overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI) of individuals diagnosed with LUAD and LUSC.